Dietary Supplement Labeling

Format	Author(s)	Title / Description	Date added	Details
	Elliott, Victoria Stagg	Code Green: Seeing the Side Effects of Alternative Supplements This report discusses side effects of herbal supplements as well as labeling and diagnosis issues. It also includes, under "Additional information," the reasons for taking, adverse reactions, and other drug conflictions of ephedra/ma huang, St. John's Wort, kava kava, yohimbine, and ginkgo biloba. (more) Publication Date: Monday, March 5, 2001	Aug 15, 2002
	Task Force on Consumer Health Information for Better Nutrition, Food and Drug Administration	Consumer Health Information for Better Nutrition Initiative: Task Force Final Report Report of this task force that was part of the Consumer Health Information for Better Nutrition Initiative. It includes the transmittal memorandum, an overview and executive summary of the situation and the work of the Task Force, and several attachments. Attachments include "Possible Regulatory Frameworks for Qualified Health Claims in the Labeling of Conventional Human Food and Dietary Supplements," "Guidance: Interim Evidence-Based Ranking System for Scientific Data," "Consumer Studies Research Agenda -- Improving Consumer Understanding and Product Competition on the Health Consequences of Dietary Choices," "Guidance: Interim Procedures for Qualified Health Claims in the Labeling of Conventional Human Food and Human Dietary Supplements," "?One-Year? Time Line for Qualified Health Claim Activities," "Task Force Membership," "Stakeholder Meetings Summary," and "Public Dockets Comments Summary". (more) Publication Date: Thursday, July 10, 2003	Jul 15, 2003
	Food and Drug Administration	Dietary Supplement Health and Education Act of 1994 Public Law 103-417, 103rd Congress. This act amends the Federal Food, Drug, and Cosmetic Act with regards to dietary supplements. (more) Publication Date: Tuesday, October 25, 1994	Jul 21, 2003
	Center for Food Safety and Applied Nutrition, Food and Drug Administration/Research Triangle Institute	Dietary Supplement Sales Database (DSPD) A survey conducted by Research Triangle Institute (RTI) under contract with FDA. The Access database contains labeling and catalogue information of approximately 3,000 dietary supplement products sold in the United States. The database includes information such as the product's name, the name and address of the manufacturer or distributor, the product's ingredients, and claims about the product. Claims may be about the health benefits or nutrient content of the product or may be nutritional support statements. Thus, the database provides information on the range of products available for sale in the United States, where these products are sold, what they contain, and what claims are being made about these products. Also available are the final report of the project, which includes information on the procedures used and a description of the database, and a supplement to the final report, which includes detailed records from the data collection process. (more) Publication Month: October 1999	Aug 16, 2002
	Office of Nutritional Products, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, Food and Drug Administration	Dietary Supplements/Food Labeling Electronic Newsletter (FDA-DSFL) Newsletter that addresses dietary supplements, food labeling and nutrition issues. Archives of past newsletters are available. (more)	Aug 7, 2002
	Food and Drug Administration	FDA Warns Distributors of Dietary Supplements Promoted Online for Weight Loss Release regarding FDA's warning to distributors of dietary supplements over the Internet regarding false and misleading claims for weight loss products. Includes a link to follow to access copies of the warning letters that were sent. (more) Publication Date: Thursday, April 1, 2004	May 3, 2004
	Food and Drug Administration	Food Labeling: Health Claims and Label Statements; Folate and Neural Tube Defects Final rule that authorizes the use of health claims on food and dietary supplement labels regarding the association between adequate folate intake and the risk of neural tube defects. Includes discussion of this association, a summary of comments in response to the proposed rule and the FDA's responses, and discussion of the economic impact of this rule. (more) Publication Date: Tuesday, March 5, 1996	Aug 4, 2004
	Food and Drug Administration	Food Labeling: Health Claims; Dietary Guidance Advance notice of proposed rulemaking, issued to solicit comments regarding the regulation of health claims and dietary guidance statements in the labeling of conventional foods and dietary supplements. The comment period has been extended. See 69 FR 3868, available through GPO Access. (more) Publication Date: Tuesday, November 25, 2003	Dec 4, 2003
	Center for Food Safety and Applied Nutrition, Food and Drug Administration	Guidance for Industry and FDA: Interim Procedures for Qualified Health Claims in the Labeling of Conventional Human Food and Human Dietary Supplements Guidance document that outlines FDA's interim procedures for responding to qualified health claim petitions. Publication Date: Thursday, July 10, 2003	Oct 25, 2004
	Center for Food Safety and Applied Nutrition, Food and Drug Administration	Guidance for Industry: A Dietary Supplement Labeling Guide Questions and answers regarding the labeling of dietary supplements, including coverage of such topics as statement of identity, net quantity of contents, nutrition labeling, ingredient labeling, claims, premarket notification of new dietary ingredients, and more. Appendices include "Daily Values for Adults and Children 4 or More Years of Age," "Daily Values for Infants, Children Less Than 4 Years of Age, and Pregnant of Lactating Women," "Nutrient Content Claims," "Authorized Health Claims," "Qualified Health Claims," and more. (more) Publication Month: April 2005	Apr 22, 2005

Copyright © 2008 Joint Institute for Food Safety and Applied Nutrition.

0220 Symons Hall University of Maryland, College Park, MD 20740

• Phone: 301.314.6806
• Fax: 301.405.8390
• E-mail: foodrisk@umd.edu